Procaps Group (NASDAQ:PROC) Stock Price Down 40.3% – Time to Sell?

Procaps Group S.A. (NASDAQ:PROC) was down 40.3% during trading on Thursday . The stock traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares changed hands during trading, an increase of 2,938% from the average daily volume of 21,666 shares. The stock had previously closed at $1.59.

Procaps Group Stock Performance

The company has a 50 day simple moving average of $1.77 and a 200 day simple moving average of $1.80.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Procaps Group stock. Itau Unibanco Holding S.A. purchased a new position in shares of Procaps Group S.A. (NASDAQ:PROC) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned about 0.16% of Procaps Group at the end of the most recent quarter.

Procaps Group Company Profile

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.